Age [years] | Median | 68 |
---|---|---|
 | Range | 36-88 |
T | pT1mi | 1 (2%) |
 | pT1a | 6 (11%) |
 | pT1b | 11 (21%) |
 | pT1c | 20 (38%) |
 | pT2 | 15 (28%) |
N | pN0 | 49 (92%) |
 | pN1 | 4 (8%) |
Histology | IDC | 41 (77%) |
 | ILC | 10 (19%) |
 | Other Invasive | 2 (4%) |
 | DCIS | 0 (0%) |
Grading | I | 10 (19%) |
 | II | 38 (72%) |
 | III | 5 (9%) |
Estrogen Receptors | Positive | 49 (92%) |
 | Negative | 4 (8%) |
Progesterone Receptors | Positive | 46 (87%) |
 | Negative | 7 (13%) |
Her-2/neu | Overexpressed | 1 (2%) |
 | Not overexp. | 52 (98%) |
Ki-67 | ≥20 | 3 (6%) |
 | <20 | 50 (94%) |
Disease Stage | 0 | 0 (0%) |
 | I | 43 (81%) |
 | II | 10 (19%) |